Table 1 Patient characteristics
Patient | Age | Sex | Height (cm) | Weight (kg) | BMI (kg/m 2 ) | BSA (m 2 ) | PS | Disease stage | Previous chemotherapy |
|---|---|---|---|---|---|---|---|---|---|
1 | 41 | F | 154.2 | 43.6 | 18.3 | 1.38 | 1 | IV | CDDP + DTX, VNR + GEM, PEM |
2 | 40 | M | 173.5 | 61.2 | 20.3 | 1.73 | 1 | IV | No previous chemotherapy. |
3 | 62 | M | 175.5 | 81.3 | 26.4 | 1.97 | 0 | IIIA | CBDCA + PTX, CDDP + DTX, Bevacizumab, CPT-11 + AMR + Bevacizumab |
4 | 75 | F | 146.4 | 36.8 | 17.2 | 1.24 | 1 | IIIA | CBDCA + PEM |
5 | 52 | F | 158.0 | 64.2 | 25.7 | 1.65 | 1 | IV | CDDP + PEM, PEM |
6 | 57 | F | 147.5 | 47.9 | 22.0 | 1.39 | 1 | IIIA | CBDCA + PTX, CDDP + VNR |
7 | 57 | F | 155.2 | 35.1 | 14.6 | 1.26 | 1 | IIA | CBDCA + PTX |
8 | 67 | F | 146.5 | 42.4 | 19.8 | 1.31 | 1 | IV | No previous chemotherapy |
9 | 54 | F | 157.8 | 58.9 | 23.7 | 1.59 | 1 | IV | CDDP + PEM, PEM |